Nov 13, 2017
On the threshold of cell therapy for Parkinson’s disease
On the threshold of cell therapy for Parkinson’s disease
By Jeanne Loring
Dopamine neurons derived from a Parkinson’s disease patient’s iPSCs (Tyrosine hydroxylase). Image source: Loring lab.
There are ten million people in the world who have Parkinson’s disease. 125,000 of these are living in California. People with the disease often have to step away from their jobs because the main symptoms – tremor or freezing up of muscles – make it difficult to…
View On WordPress